Researchers are currently investigating whether:
Information about clinical trials is available from the National Institute of Health's National Cancer Institute.
There are no known risk factors for lung carcinoids, and no methods of prevention are known.
See Also Neuroendocrine carcinomas; Bronchoscopy
"New NCCN Recommendations for Small-Cell Lung Cancer." Oncology News International 10, no. 4 (April 2001).
National Carcinoid Support Group, Inc. 6666 Odana Rd., #146, Madison, WI 53719-1012. <http://members.aol.com/thencsg/info.html>.
National Cancer Institute. CancerNet 28 May 2001 <http://cancernet.nci.nih.gov>.
"Lung Carcinoid Tumor." Lung Carcinoid Tumor Research Center. 23 May 2000. 2 April 2001. 2 July 2001 <http://www3.cancer.org>.
"Lung Tumors: A Multidisciplinary Database." Virtual Hospital. August 1999. 27 May 2001. 2 July 2001 <http://www.vh.org/Providers/Textbooks/LungTumors/TitlePage.html>.
Maureen Haggerty
—Hormonal disorder causing progressive enlargement of hands and feet and elongation of the face, headache, muscle pain, and visual and emotional disturbances in middle-aged men and women.
—Rare malignant disease characterized by facial flushing, abdominal cramps, diarrhea, breathlessness, and other symptoms. Affects fewer than 10% of patients with carcinoid tumor.
—Hormonal disorder characterized by a round face, mental or emotional instability, high blood pressure, weight gain, or abnormal growth of facial and body hair in women.
—Abnormal lung condition characterized by breathing problems, cough, rapid heartbeat. Later stages are characterized by restlessness, weakness, confusion, increased breathlessness, and may cause fluid to collect around the lungs (pulmonary edema) and congestive heart failure.
—Abnormally high levels of calcium in the blood, causing muscle pain and weakness and loss of appetite. Severe cases can result in kidney failure.
|
|
Author Info: Maureen Haggerty, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Cancer, 2002 |